Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Screening for cancer has gotten more complicated in recent years with evolving guidelines that sometimes conflict. Now a doctors' group aims to ease some confusion — and encourage more discussion of testing's pros and cons.
read more
Medidata, a global provider of cloud-based solutions for clinical research in life sciences, has announced that Forty Seven Inc., a new biotechnology company specializing in cancer immunotherapy, is powering two upcoming anti-cancer studies with the ...
read more
MediPharm Labs Corp., a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, has received a Drug Establishment Licence (the “DEL”) issued by Health Canada in accordance with the ...
read more
Thursday, October 10, 2019
The Cannabis Packaging Summit will take place February 11 and 12, 2020 at the Anaheim Convention Center, in Anaheim, CA, adjacent to WestPack.
read more
InterCure announced Canndoc has entered into a strategic partnership agreement with Super-Pharm.
read more
Canopy Biosciences has acquired Zellkraftwerk GmbH, a leader in multiplex cytometry.
read more
Canopy Biosciences has partnered with OnRamp BioInformatics™ to offer their ROSALIND™ interactive data analysis platform for Canopy's gene expression services.
read more
CanSino Biologics and Precision NanoSystems announced a co-development agreement of a mRNA lipid nanoparticle vaccine against COVID-19.
read more
Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENT® Technology for production of Cantargia's antibody drug candidate CAN04, which gives Cantargia broader rights to use the technology...
read more
Cantargia and Patheon Biologics have signed an agreement regarding future production of the antibody CAN04 (nidanilimab).
read more
Tuesday, September 25, 2018
Cantrell Drug Company, a 503B Registered Outsourcing Facility, announced that the company has received final approval from the FDA to begin producing and shipping product.
read more
Friday, December 12, 2014
Capillary Film Technology Limited (CFT), a UK based technology and product development company for life sciences and clinical diagnostics, today announced it has received £1 million in funding through a Phase 2 Small Business Research Initiative for ...
read more
Tuesday, February 17, 2026
Capricorn Scientific has expanded its European operations with a new 4,000m² logistics and infrastructure hub in Ebsdorfergrund, Germany.
read more
Caprion Biosciences has announced the company acquired Serametrix Corporation, a specialized provider of immune monitoring services headquartered in Carlsbad, California.
read more
Tuesday, January 08, 2019
Caprion Biosciences announced it is offering mass cytometry services to advance biomarker discovery and immune monitoring.
read more